QuidelOrtho Corp (QDEL)
40.23
+0.54
(+1.36%)
USD |
NASDAQ |
Apr 26, 10:16
QuidelOrtho Cash from Operations (TTM): 280.20M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 280.20M |
September 30, 2023 | 369.20M |
June 30, 2023 | 318.00M |
March 31, 2023 | 573.30M |
December 31, 2022 | 885.30M |
September 30, 2022 | 1.037B |
June 30, 2022 | 1.124B |
March 31, 2022 | 721.34M |
December 31, 2021 | 805.90M |
September 30, 2021 | 923.63M |
June 30, 2021 | 917.09M |
March 31, 2021 | 1.154B |
December 31, 2020 | 629.76M |
September 30, 2020 | 238.36M |
June 30, 2020 | 181.23M |
March 31, 2020 | 162.77M |
December 31, 2019 | 134.48M |
September 30, 2019 | 129.98M |
June 30, 2019 | 146.93M |
March 31, 2019 | 133.43M |
December 31, 2018 | 136.34M |
September 30, 2018 | 104.35M |
June 30, 2018 | 66.54M |
March 31, 2018 | 33.95M |
December 31, 2017 | 27.71M |
Date | Value |
---|---|
September 30, 2017 | 33.10M |
June 30, 2017 | 38.28M |
March 31, 2017 | 48.99M |
December 31, 2016 | 11.82M |
September 30, 2016 | 11.82M |
June 30, 2016 | 11.16M |
March 31, 2016 | -2.483M |
December 31, 2015 | 36.88M |
September 30, 2015 | 38.46M |
June 30, 2015 | 41.66M |
March 31, 2015 | 45.30M |
December 31, 2014 | 35.69M |
September 30, 2014 | 18.94M |
June 30, 2014 | 13.66M |
March 31, 2014 | 13.39M |
December 31, 2013 | 25.68M |
September 30, 2013 | 37.97M |
June 30, 2013 | 43.77M |
March 31, 2013 | 50.38M |
December 31, 2012 | 19.63M |
September 30, 2012 | 19.13M |
June 30, 2012 | 18.54M |
March 31, 2012 | 25.17M |
December 31, 2011 | 47.54M |
September 30, 2011 | 37.47M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
129.98M
Minimum
Sep 2019
1.154B
Maximum
Mar 2021
564.88M
Average
573.30M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Abbott Laboratories | 7.261B |
Becton Dickinson & Co | 3.43B |
Boston Scientific Corp | 2.503B |
Tenon Medical Inc | -12.18M |
Perspective Therapeutics Inc | -36.91M |